LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Prothena Corp PLC

Închisă

SectorSănătate

5.39 6.52

Rezumat

Modificarea prețului

24h

Curent

Minim

5.01

Maxim

5.43

Indicatori cheie

By Trading Economics

Venit

-2.2M

-60M

Vânzări

705K

2.8M

EPS

-1.12

Marjă de profit

-2,128.536

Angajați

163

EBITDA

-682K

-65M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+380.04% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-495M

251M

Deschiderea anterioară

-1.13

Închiderea anterioară

5.39

Sentimentul știrilor

By Acuity

50%

50%

167 / 380 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

Prothena Corp PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 iun. 2025, 20:45 UTC

Câștiguri

Broadcom 2Q Sales Climb on Booming AI Demand

5 iun. 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 iun. 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 iun. 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 iun. 2025, 21:32 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5 iun. 2025, 20:45 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:24 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Rev $15B >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Net $4.97B >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Adj EPS $1.58 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q EPS $1.03 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom Sees 3Q Rev $15.8B >AVGO

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 iun. 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5 iun. 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 iun. 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5 iun. 2025, 18:26 UTC

Câștiguri

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 iun. 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 iun. 2025, 16:30 UTC

Achiziții, Fuziuni, Preluări

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 iun. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5 iun. 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 iun. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5 iun. 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5 iun. 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 iun. 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 iun. 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Prothena Corp PLC Așteptări

Obiectiv de preț

By TipRanks

380.04% sus

Prognoză pe 12 luni

Medie 24.29 USD  380.04%

Maxim 81 USD

Minim 4 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruProthena Corp PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

9 ratings

4

Cumpărare

4

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

N/A / 7.35Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Very Strong Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

167 / 380 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Prothena Corp PLC

Prothena Corporation PLC is a late-stage clinical company. The Company is engaged in the protein dysregulation and a pipeline of therapeutics for devastating neurodegenerative and rare peripheral amyloid diseases. It is advancing a pipeline of therapeutic candidates around neurological dysfunction and the biology of misfolded proteins. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Birtamimab for the treatment of amyloid light-chain (AL) amyloidosis; prasinezumab for the treatment of Parkinson’s disease and other related synucleinopathies; and PRX004, for the treatment of Transthyretin amyloidosis (ATTR). The Company's pipeline also includes late-preclinical-stage programs targeting proteins implicated in neurological diseases including tau and amyloid beta (Aß) for the treatment of Alzheimer’s disease and other neurodegenerative disorders, and TDP-43 for the treatment of amyotrophic lateral sclerosis.